DelRossi AJ, Cernaianu AC, Vertrees RA, et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;100(2):281–6.
Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, et al. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987;10(1):47–50.
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol En-dod. 1998;85(6):638–46.
Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529–35.
Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226–50.
Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–16.
Cheung EV, Silverio L, Sperling JW. Strategies in biologic augmentation of rotator cuff repair: a review. Clin Orthop Relat Res. 2010;468:1476–148.
Malanga GA, Goldin M. PRP: review of the current evidence of the current evidence of musculoskeletal conditions. Curr Phys Med Rehab. 2014;2(1):1–15.
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37:2259–72.
Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39.
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.
Scherer SS, Tobalem M, Vigato E, et al. Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-myofibroblast differentiation in vivo and in vitro. Plas Reconstr Surg. 2012;129(1):46e–54e.
Geaney LE, Arciero RA, DeBarradino TM, Mazzocca AD. The effects of platelet-rich plasma on tendon and ligament: basic science and clinical application. Oper Tech Sports Med. 2011;19(3):160–4.
Anitua E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23:281–6.
Zhou Y, Wang J. PRP treatment efficacy for tendinopathy: a review of basic science studies. Biomed Res Int. 2016;2016:1–8. https://doi.org/10.1155/2016/9103792.
Zhang J, Wang JH. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. AJSM. 2010;38(12):2477–86.
Chen L, Dong SW, Tao X, Liu JP, Tang KL, Xu JZ. Autologous platelet-rich clot releasate stimulates proliferation and inhibits differentiation of adult rat tendon stem cells towards nontenocyte lineages. J Int Med Res. 2012;40(4):1399–409.
McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27(8):1033–42.
Intravia J, Allen DA, Durant TJS, et al. In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood. Muscles, Ligaments, and Tendon Journal. 2014;4(1):79–84.
Madry H, Kohn D, Cucchiarini M. Direct FGF-2 gene transfer via recombinant adeno-associated virus vectors stimulates cell proliferation, collagen production, and the repair of experimental lesions in the human ACL. Am J Sports Med. 2013;41:194–202.
Marui T, Niyibizi C, Georgescu HI, Cao M, Kavalkovich KW, Levine RE, et al. Effect of growth factors on matrix synthesis by ligament fibroblasts. J Orthop Res. 1997;15:18–23.
Hildebrand KA, Woo SL-Y, Smith DW, Allen CR, Deie M, Taylor BJ, et al. The effects of platelet derived growth factor-BB on healing of the rabbit medial collateral ligament: an in vivo study. Am J Sports Med. 1998;26:549–54.
Batten ML, Hansen JC, Dahners LE, et al. Influence of dosage and timing of application of platelet derived growth factor on early healing of the rat medial collateral ligament. J Orthop Res. 1996;14:736–41.
Fleming BC, Spindler KP, Palmer MP, Magarian EM, Murray MM. Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model. Am J Sports Med. 2009;37:1554–63.
Hak A, Rajaratnam K, Ayeni OR, Moro J, Peterson D, Sprague S, et al. A double-blinded placebo randomized controlled trial evaluating short-term efficacy of platelet-rich plasma in reducing postoperative pain after arthroscopic rotator cuff repair: a pilot study. Sports Health. 2015;7(1):58–66.
Zhao JG, Zhao L, Jiang YX, Wang ZL, Wang J, Zhang P. Platelet-rich plasma in arthroscopic rotator cuff repair: a meta- analysis of randomized controlled trials. Arthroscopy. 2015 Jan;31(1):125–35.
• Hurley ET, Lim Fat D, Moran CJ, Mullett H. The efficacy of platelet-rich plasma and platelet-rich fibrin in arthroscopic rotator cuff repair: a meta-analysis of randomized controlled trials. Am J Sports Med. 2018; https://doi.org/10.1177/03635465177513997. This metanalysis encompassed over 18 randomized controlled trials with over 1147 patients and was recently published this year. Their findings found significant improvement with pain and healing after rotator cuff repair using PRP.
Verhaegen F, Brys P, Debeer P. Rotator cuff healing after needling of calcific deposit using platelet-rich plasma augmentation: a randomized, prospective clinical trial. J Shoulder Elb Surg. 2016;25(2):169–73.
Carr A, Murphy R, Dakin S, Rombach I, et al. Platelet-rich plasma injection with arthroscopic acriomioplasty for chronic rotator cuff tendinopathy. Am J Sports Med. 2015;43(12):2891–7.
Rha DW, Park GY, Kim YK, Kim MT, Lee SC. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehab. 2013;27(2):113–22.
Shams A, El-Sayed M, Gamal O, Ewes W. Subacromial injection of autologous platelet-rich plasma versus corticosteroid for the treatment of symptomatic partial rotator cuff tears. Eur J Orthop Surg Traumatol. 2016;26(8):837–42.
Liddle AD, Rodríguez-Merchán C. Platelet-rich plasma in the treatment of patellar tendinopathy: a systematic review. Am J Sports Med. 2015;Oct: 43(10):2583–90.
Gosens T, Den Oudsten BL, et al. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36(9):1941–6.
Zayni R, Thaunat M, Fayard JM, et al. Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections. Muscles Ligaments Tendons J. 2015;5(2):92–8.
Abate M, Di Carlo L, Verna S, Di Gregorio P, Schiavone C, Salini V. Synergistic activity of platelet rich plasma and high volume image guided injection for patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2018; https://doi.org/10.1007/s00167-018-4930-6.
Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int Orthop. 2010;34(6):909–15.
Kaux JF, Bruyere O, Croisier JL, Forthomme B, Leo Goff C, Crielaard JM. One-year follow-up of plate-rich plasma infiltration to treat chronic proximal patellar tendinopathies. Acta Orthop Belg. 2015;81(2):251–6.
• Andriolo L, Sante Altamura SA, et al. Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis. Am J Sports Med. 2018;363546518759674 https://doi.org/10.1177/0363546518759674. They conducted a systematic analysis in 2017 and found PRP to be a suitable option for chronic tendinopathy and also demonstrated that number of injections along with incorporation of physical therapy were important in treatment.
Cervellin M, de Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc. 2012;20(1):114–20.
Walters BL, Porter DA, Hobart SJ, Bedford BB, Hogan DE, McHugh MM, et al. Effect of intraoperative platelet-rich plasma treatment on postoperative donor site knee pain in patellar tendon autograft anterior cruciate ligament reconstruction: a double-blind randomized controlled trial. AJSM. 2018;46(8):1827–35.
Dayton P. Anatomic, vascular, and mechanical overview of the Achilles tendon. Clin Podiatr Med Surg. 2017;34(2):107–13.
Benjamin M, Toumi H, Ralphs JR, Bydder G, Best TM, Milz S. Where tendons and ligaments meet bone: attachment sites (‘entheses’) in relation to exercise and/or mechanical load. J Anat. 2006;208(4):471–90.
Di Matteo B, Kon GFE. Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy — a systematic review. Musculoskelet Surg. 2015;99(1):1–9.
de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144–9.
Boesen AP, Hansen R, Boesen MI, Malliaras P, Langberg H. Effect of high-volume injection , platelet- rich plasma, and sham treatment in chronic midportion Achilles tendinopathy. Am. J. Sports Med. 2017;45(9):2034–43.
Brummel J, Baker CL, Hopkins R, Baker CL. Epicondylitis: lateral. Sports Med Arthrosc Rev. 2014 Sep;22(3):e1–6.
Ahmad Z, Siddiqui N, Malik SS, Abdus-Samee M, Tytherleigh-Strong G, Rushton N. Lateral epicondylitis: a review of pathology and management. Bone Jt J. 2013 Sep;95-B(9):1158–64.
Chen X, Jones IA, Park C, Vangsness CT. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2018 Jul;46(8):2020–32.
• Mi B, Liu G, Zhou W, Lv H, Liu Y, Wu Q, et al. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sports Med. 2017;45(2):97–104. This study was important because it examined eight randomized controlled trials involving over 511 patients. Their study revealed that cortisone injection was helpful in the short-term, as opposed to PRP which was much more effective in long-term patient outcomes.
Ben-Nafa W, Munro W. The effect of corticosteroid versus platelet-rich plasma injection therapies for the management of lateral epicondylitis: a systematic review. SICOT-J. 2018;4:11.
• Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463–71. In this study, the authors performed a double-blinded randomized control trial involving over 230 patients and further proved that patients treated with leukocyte-enriched PRP was more effective than the control group.
Merolla G, Dellabiancia F, Ricci A, Mussoni MP, Nucci S, Zanoli G, et al. Arthroscopic debridement versus platelet-rich plasma injection: a prospective, randomized, comparative study of chronic lateral epicondylitis with a nearly 2-year follow-up. Arthrosc J Arthrosc Relat Surg. 2017 Jul;33(7):1320–9.
Park SK, Choic YK, Kim HJ. Hypopigmentation and subcutaneous fat, muscle, atrophy after local corticosteroid injection. Korean J Anesthesiol. 2013;65(6):59–61.
Clark NJ, Desai VS, Dines JD, Morrey ME, Camp CL. Nonreconstruction options for treating medial ulnar collateral ligament injuries of the elbow in overhead athletes. Curr Rev Musculoskelet Med. 2018 Mar;11(1):48–54.
Podesta L, Crow SA, Volkmer D, Bert T, Yocum LA. Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. Am J Sports Med. 2013;41(7):1689–94.
Hoffman JK, Protzman NM, Malhotra AD. Biologic augmentation of the ulnar collateral ligament in the elbow of a professional baseball pitcher. Case Rep Orthop. 2015;2015:130157.
Dines JS, Wiliams PN, ElAttrache N, Conte S, Ahmad CS, et al. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficency in high-level throwers. Am J Orthop. 2016;45(5):296–300.
Deal JB, Smith E, Heard W, O'Brien MJ, Savoie FH. Platelet-rich plasma for primary treatment of partial ulnar collateral ligament tears: MRI correlation with results. Orthop J Sports Med. 2017;5(11):2325967117738238.
Figueroa D, Figueroa F, Calvo R, Vaisman A, Ahumada X, Arellano S. Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. J of Arth and Rel Surg. 2015;31(5):981–8.
Mirzatolooei F, Alamdari MT, Khalkhali HR. The impact of platelet-rich plasma on the prevention of tunnel widening in anterior cruciate ligament reconstruction using quadrupled autologous hamstring tendon: a randomized clinical trial. Bone Joint J. 2013;95-B(1):65–9.
Vadala A, Iorio R, De Carli A, et al. Platelet-rich plasma: does it help reduce tunnel widening after ACL reconstruction? Knee Surg Sports Traumatol Arthrosc. 2013;21(4):824–9.
Rupreht M, Vogrin M, Hussein M. MRI evaluation of tibial tunnel wall cortical bone formation after platelet-rich plasma applied during anterior cruciate ligament reconstruction. Radiol Oncol. 2013;47(2):118–24.
Vogrin M, Rupreht M, Crnjac A, Dinevski D, Krajnc Z, Recnik G. The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wien Klin Wochenschrift. 2010;122(S2):91–5.
Magnussen RA, Flanigan DC, Pedroza AD, Heinlein KA, Kaeding CC. Platelet rich plasma use in allograft ACL reconstructions: two-year clinical results of a MOON cohort study. Knee. 2013;20(4):277–80. https://doi.org/10.1016/j.knee.2012.12.001.
Di Matteo B, Loibl M, Andriolo L, et al. Biologic agents for anterior cruciate ligament healing: a systematic review. World J of Orthop. 2016;7(9):592–603.